APA (7th ed.) Citation

Lin, J., Zhang, J., Su, N., Xu, J., Wang, N., Chen, J., . . . Dong, X. (2007). Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine. Antiviral therapy, 12(7), 1107-1114. https://doi.org/10.1177/135965350701200702

Chicago Style (17th ed.) Citation

Lin, Jiang-Tao, et al. "Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine." Antiviral Therapy 12, no. 7 (2007): 1107-1114. https://doi.org/10.1177/135965350701200702.

MLA (9th ed.) Citation

Lin, Jiang-Tao, et al. "Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine." Antiviral Therapy, vol. 12, no. 7, 2007, pp. 1107-1114, https://doi.org/10.1177/135965350701200702.